- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
By 
Kyle Brasseur2023-11-15T15:46:00
A big year for disgorgement helped the Securities and Exchange Commission (SEC) to its second highest total of financial remedies ordered in a single year in fiscal year 2023.
The agency’s FY23 enforcement results, released Tuesday, noted it obtained orders for nearly $5 billion in financial remedies during the year, which ended Sept. 30. The total fell short of the record $6.4 billion in enforcement penalties, fees, and interest the SEC collected in FY22.
Unlike FY22’s totals, which were driven largely by a record $4.2 billion in civil penalties, the SEC relied more on disgorgement and prejudgment interest for its enforcement success in FY23. Financial remedies comprised nearly $3.4 billion in disgorgement and prejudgment interest and nearly $1.6 billion in civil penalties, both the second highest amounts on record.
THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.
News and analysis for the well-informed compliance or audit exec. Select an option and click continue.
Annual Membership $499 Value offer
Full price one year membership with auto-renewal.
Membership $599
One-year only, no auto-renewal.
Gurbir Grewal, director of the Enforcement Division at the Securities and Exchange Commission, spelled out plainly his view on the best path to earning cooperation credit during settlement negotiations with the agency.
A subsidiary of JPMorgan Chase will pay an $18 million fine to the Securities and Exchange Commission for allegedly violating the agency’s whistleblower protection rule in hundreds of settlement agreements with clients and customers.
In this episode of the Digital Transformation of Compliance podcast series, Kyle Welch, a George Washington University associate professor of accountancy, discusses findings from his research on internal whistleblowing and compliance dashboards built by publicly traded U.S. companies to leverage hotline data.
USAA Federal Savings Bank has been hit with its third cease and desist order from the Treasury Department’s Office of the Comptroller of the Currency in the past five years for failing to correct unsafe and unsound banking practices.
Becton Dickinson medical device company will pay $175 million for “repeatedly” misleading investors about its Alaris infusion pump, a product the company knew was flawed and was sold without the required patient-safety approvals, the Securities and Exchange Commission said.
The Securities and Exchange Commission charged bankrupt fashion retailer Express with failing to disclose nearly $1 million in perks to a former chief executive, but did not levy a financial penalty thanks to its cooperation, the SEC said.
